In agreement with expectations expressed in the comment letter by Heyman et al. (1), most of the patients (72%) included in...
Auteur - American Diabetes Association - Care
Response to Comment on Fahrmann et al. Modification of the...
We thank Dr. González-Clemente et al. (1) for their comments on our article (2). We showed that in the young cohort with...
Immune Checkpoint Inhibitors and Risk of Type 1 Diabetes
OBJECTIVEType 1 diabetes mellitus (T1DM) is a rare, irreversible immune-related adverse event reported in patients receiving...
Erratum. Controversies Around the Measurement of Blood Ketones to...
In the article cited above, Joint British Societies (JBS) was inadvertently cited throughout the text. The correct society...
Erratum. Effects of the SGLT2 Inhibitor Dapagliflozin on Energy...
In the article cited above, a composition error resulted in the omission of references 30–35, and the reference Cusi et al...
Erratum. COVID-19 Severity Is Tripled in the Diabetes Community: A...
In the article cited above, a transcription error resulted in the presentation of incorrect data for three entries in Table...
Dapagliflozin Impairs the Suppression of Endogenous Glucose...
OBJECTIVETo examine the effect of SGLT2 inhibitors (SGLT2i) on endogenous glucose production (EGP) in patients with type 2...
Lack of Evidence for a Causal Role of Hyperinsulinemia in the...
OBJECTIVEThe carbohydrate-insulin model (CIM) claims that chronic exposure to hyperinsulinemia induced by dietary...
Erratum. 2022 National Standards for Diabetes Self-Management...
In the article cited above, Jody Davis’s affiliation was incorrectly listed as Dignity Health, San Francisco, CA. The...
Characteristics and Clinical Course of Diabetes of the Exocrine...
OBJECTIVEThe natural course of diabetes of the exocrine pancreas (DEP) is not well established. We aimed to compare the risk...